Literature DB >> 16626748

MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.

Marco Rovaris1, Giancarlo Comi, Massimo Filippi.   

Abstract

Studies with conventional magnetic resonance imaging (MRI) indicate that cognitive impairment in multiple sclerosis (MS) patients is not fully explained by the burden of T2-visible lesions in the brain. Other non-conventional MRI techniques with increased specificity to the more destructive aspects of MS pathology, such as magnetization transfer MRI, diffusion-weighted MRI and proton magnetic resonance spectroscopy, have recently been applied to MS cognitive studies. The results suggest that the presence and extent of "occult" MS pathological features in the normal-appearing brain tissue and the location of lesions in eloquent sites play a central role in the pathogenesis of MS neuropsychological impairment.

Entities:  

Mesh:

Year:  2006        PMID: 16626748     DOI: 10.1016/j.jns.2005.07.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  21 in total

1.  Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study.

Authors:  Céline Louapre; Vincent Perlbarg; Daniel García-Lorenzo; Marika Urbanski; Habib Benali; Rana Assouad; Damien Galanaud; Léorah Freeman; Benedetta Bodini; Caroline Papeix; Ayman Tourbah; Catherine Lubetzki; Stéphane Lehéricy; Bruno Stankoff
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

2.  Decreased frontal lobe gray matter perfusion in cognitively impaired patients with secondary-progressive multiple sclerosis detected by the bookend technique.

Authors:  R I Aviv; P L Francis; R Tenenbein; P O'Connor; L Zhang; A Eilaghi; L Lee; T J Carroll; J Mouannes-Srour; A Feinstein
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

3.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  Laura C Politte; Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Sleep and Cognitive Function in Multiple Sclerosis.

Authors:  Tiffany J Braley; Anna L Kratz; Neeraj Kaplish; Ronald D Chervin
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

Review 5.  Cortical lesions in multiple sclerosis.

Authors:  Massimiliano Calabrese; Massimo Filippi; Paolo Gallo
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

6.  Robust perfusion deficits in cognitively impaired patients with secondary-progressive multiple sclerosis.

Authors:  P L Francis; R Jakubovic; P O'Connor; L Zhang; A Eilaghi; L Lee; T J Carroll; J Mouannes-Srour; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

Review 7.  The contribution of MRI in assessing cognitive impairment in multiple sclerosis.

Authors:  M Filippi; M A Rocca; R H B Benedict; J DeLuca; J J G Geurts; S A R B Rombouts; M Ron; G Comi
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

Review 8.  Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review.

Authors:  Blandine Grassiot; Béatrice Desgranges; Francis Eustache; Gilles Defer
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

9.  Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.

Authors:  Gianna Riccitelli; Maria A Rocca; Elisabetta Pagani; Maria E Rodegher; Paolo Rossi; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2010-08-25       Impact factor: 5.038

Review 10.  Ocular motor signatures of cognitive dysfunction in multiple sclerosis.

Authors:  Joanne Fielding; Meaghan Clough; Shin Beh; Lynette Millist; Derek Sears; Ashley N Frohman; Nathaniel Lizak; Jayne Lim; Scott Kolbe; Robert L Rennaker; Teresa C Frohman; Owen B White; Elliot M Frohman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.